. >>> biogen said one of its drugs to treat alzheimer's failed to meet one of its main goals during a study. the company plans to finish the trial to gather additional data. investors sent shares of biogen down 3% to $322.52. >>> metal and glass maker apogee enterprises says it's seeing solid performance in the majorif its segments of the business. the company's results, however, did not impress invests. sales and profits climbed higher but failed to beat estimates. shares fell 16% to $42.32. >>> some iphone owners had suspicions that apple was slowing the operation of older phones. now apple is pretty much confirming it. but the company says it is doing so on purpose as a way to help older batteries perform better after a new version of ios is downloaded. >> sure they are. >>> a new report on facebook is raising concerns about age discrimination rel job ads that appear on its site. but as our julia boorstin repo now, the company is refuting those claims. >> reporter: pro publica reported that dozens of companies use facebook to exclude older workers from job ads, saying that verizon,

bio jent -- one that biogen is developing.eck on media in the wake of the 21st century fox disney deal. interesting because disney was trading lower in the session. now it is up 3% as 21st century fox prices by nearly 6%. finally, as we talk about deals, there to be one in the snack business. , the pretzel maker, is spiking after the company hired have astment make to takeover offer from campbell's soup. they have been looking for other sources of revenue. looking to expand snacking -- looking to expand in snacking. shares of 13%. scarlet: soup and pretzels. sampling our lunch, julia. [laughter] scarlet: let us get a check on the headlines. mark: so sad. i will get you lunch. the white house says president trump and paul ryan has spoken by phone about reports that ryan has not taken congress passed 2018. >> the president did speak to the speaker not too long ago and made sure the speaker new very quick -- knew very clearly. and if the news yesterday was very unhappy. the speaker assure the president that those were not accurat

alzheimer's, be more skeptical than you'd be with a disease that's easier to treat this happened with biogen. so many drug companies have failed trying to fight alzheimer's that it's way too arrogant to bet that you're on the right path with any one company's research department. so here's the bottom line. kwhn you'when you're going to is a company with a potential cure for an intractable illness, make sure that company has multiple drugs away from it in the pipeline and a good balance sheet as well as a dividend to protect the downside second, if the drug doesn't initially work but it hasn't been written off, expect a bounce a better time to sell. third, don't buy the stock when there's still a ton of hoopla out there about the new drug wait until the fuss dies down to get a better price for the stock. finally, when you have a drug company up against a difficult disease that many others have failed to cure, please be more skeptical. there is a reason that others failed it's an incredibly difficult problem to solve the company you like might fail too. investing can be a challenge, but now yo